189 related articles for article (PubMed ID: 26806387)
1. Validating Alzheimer's disease micro RNAs using next-generation sequencing.
Keller A; Backes C; Haas J; Leidinger P; Maetzler W; Deuschle C; Berg D; Ruschil C; Galata V; Ruprecht K; Stähler C; Würstle M; Sickert D; Gogol M; Meder B; Meese E
Alzheimers Dement; 2016 May; 12(5):565-76. PubMed ID: 26806387
[TBL] [Abstract][Full Text] [Related]
2. Serum MicroRNA Profiles Serve as Novel Biomarkers for the Diagnosis of Alzheimer's Disease.
Dong H; Li J; Huang L; Chen X; Li D; Wang T; Hu C; Xu J; Zhang C; Zen K; Xiao S; Yan Q; Wang C; Zhang CY
Dis Markers; 2015; 2015():625659. PubMed ID: 26078483
[TBL] [Abstract][Full Text] [Related]
3. Machine Learning to Detect Alzheimer's Disease from Circulating Non-coding RNAs.
Ludwig N; Fehlmann T; Kern F; Gogol M; Maetzler W; Deutscher S; Gurlit S; Schulte C; von Thaler AK; Deuschle C; Metzger F; Berg D; Suenkel U; Keller V; Backes C; Lenhof HP; Meese E; Keller A
Genomics Proteomics Bioinformatics; 2019 Aug; 17(4):430-440. PubMed ID: 31809862
[TBL] [Abstract][Full Text] [Related]
4. Serum microRNA miR-501-3p as a potential biomarker related to the progression of Alzheimer's disease.
Hara N; Kikuchi M; Miyashita A; Hatsuta H; Saito Y; Kasuga K; Murayama S; Ikeuchi T; Kuwano R
Acta Neuropathol Commun; 2017 Jan; 5(1):10. PubMed ID: 28137310
[TBL] [Abstract][Full Text] [Related]
5. Altered microRNAs related to synaptic function as potential plasma biomarkers for Alzheimer's disease.
Siedlecki-Wullich D; Català-Solsona J; Fábregas C; Hernández I; Clarimon J; Lleó A; Boada M; Saura CA; Rodríguez-Álvarez J; Miñano-Molina AJ
Alzheimers Res Ther; 2019 May; 11(1):46. PubMed ID: 31092279
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide serum microRNA expression profiling identifies serum biomarkers for Alzheimer's disease.
Tan L; Yu JT; Tan MS; Liu QY; Wang HF; Zhang W; Jiang T; Tan L
J Alzheimers Dis; 2014; 40(4):1017-27. PubMed ID: 24577456
[TBL] [Abstract][Full Text] [Related]
7. A blood based 12-miRNA signature of Alzheimer disease patients.
Leidinger P; Backes C; Deutscher S; Schmitt K; Mueller SC; Frese K; Haas J; Ruprecht K; Paul F; Stähler C; Lang CJ; Meder B; Bartfai T; Meese E; Keller A
Genome Biol; 2013 Jul; 14(7):R78. PubMed ID: 23895045
[TBL] [Abstract][Full Text] [Related]
8. Circulating microRNAs as Biomarkers of Alzheimer's Disease: A Systematic Review.
Wu HZ; Ong KL; Seeher K; Armstrong NJ; Thalamuthu A; Brodaty H; Sachdev P; Mather K
J Alzheimers Dis; 2016; 49(3):755-66. PubMed ID: 26484928
[TBL] [Abstract][Full Text] [Related]
9. Circulating miR-125b as a biomarker of Alzheimer's disease.
Tan L; Yu JT; Liu QY; Tan MS; Zhang W; Hu N; Wang YL; Sun L; Jiang T; Tan L
J Neurol Sci; 2014 Jan; 336(1-2):52-6. PubMed ID: 24139697
[TBL] [Abstract][Full Text] [Related]
10. Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease.
Geekiyanage H; Jicha GA; Nelson PT; Chan C
Exp Neurol; 2012 Jun; 235(2):491-6. PubMed ID: 22155483
[TBL] [Abstract][Full Text] [Related]
11. Downregulated serum miR-223 servers as biomarker in Alzheimer's disease.
Jia LH; Liu YN
Cell Biochem Funct; 2016 Jun; 34(4):233-7. PubMed ID: 27027823
[TBL] [Abstract][Full Text] [Related]
12. Micro RNA as a potential blood-based epigenetic biomarker for Alzheimer's disease.
Fransquet PD; Ryan J
Clin Biochem; 2018 Aug; 58():5-14. PubMed ID: 29885309
[TBL] [Abstract][Full Text] [Related]
13. Serum miR-206 and miR-132 as Potential Circulating Biomarkers for Mild Cognitive Impairment.
Xie B; Zhou H; Zhang R; Song M; Yu L; Wang L; Liu Z; Zhang Q; Cui D; Wang X; Xu S
J Alzheimers Dis; 2015; 45(3):721-31. PubMed ID: 25589731
[TBL] [Abstract][Full Text] [Related]
14. Dysregulation and diagnostic potential of microRNA in Alzheimer's disease.
Pan Y; Liu R; Terpstra E; Wang Y; Qiao F; Wang J; Tong Y; Pan B
J Alzheimers Dis; 2016; 49(1):1-12. PubMed ID: 26484912
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic and therapeutic biomarkers for Alzheimer's disease in human-derived platelets.
Min JW; Lee J; Mun HJ; Kim DH; Park BG; Yoon B; Ryu JH; Cho HJ
Genes Genomics; 2020 Dec; 42(12):1467-1475. PubMed ID: 33180258
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for Early Diagnostic of Mild Cognitive Impairment in Type-2 Diabetes Patients: A Multicentre, Retrospective, Nested Case-Control Study.
Xu ZP; Yang SL; Zhao S; Zheng CH; Li HH; Zhang Y; Huang RX; Li MZ; Gao Y; Zhang SJ; Zhan PY; Zhang LF; Deng L; Wei S; Liu YC; Ye JW; Ren HJ; Li N; Kong CX; Wang X; Fang L; Zhou QZ; Jiang HW; Li JR; Wang Q; Ke D; Liu GP; Wang JZ
EBioMedicine; 2016 Mar; 5():105-13. PubMed ID: 27077117
[TBL] [Abstract][Full Text] [Related]
17. Buccal Cell Cytokeratin 14 Correlates with Multiple Blood Biomarkers of Alzheimer's Disease Risk.
Leifert WR; Nguyen T; Rembach A; Martins R; Rainey-Smith S; Masters CL; Ames D; Rowe CC; Macaulay SL; François M; Fenech MF;
J Alzheimers Dis; 2015; 48(2):443-52. PubMed ID: 26402008
[TBL] [Abstract][Full Text] [Related]
18. A blood-based, 7-metabolite signature for the early diagnosis of Alzheimer's disease.
Olazarán J; Gil-de-Gómez L; Rodríguez-Martín A; Valentí-Soler M; Frades-Payo B; Marín-Muñoz J; Antúnez C; Frank-García A; Acedo-Jiménez C; Morlán-Gracia L; Petidier-Torregrossa R; Guisasola MC; Bermejo-Pareja F; Sánchez-Ferro Á; Pérez-Martínez DA; Manzano-Palomo S; Farquhar R; Rábano A; Calero M
J Alzheimers Dis; 2015; 45(4):1157-73. PubMed ID: 25649659
[TBL] [Abstract][Full Text] [Related]
19. Identifying Alzheimer's Disease-related miRNA Based on Semi-clustering.
Zhao T; Wang D; Hu Y; Zhang N; Zang T; Wang Y
Curr Gene Ther; 2019; 19(4):216-223. PubMed ID: 31549953
[TBL] [Abstract][Full Text] [Related]
20. Peripheral Blood MicroRNA Expression Profiles in Alzheimer's Disease: Screening, Validation, Association with Clinical Phenotype and Implications for Molecular Mechanism.
Ren RJ; Zhang YF; Dammer EB; Zhou Y; Wang LL; Liu XH; Feng BL; Jiang GX; Chen SD; Wang G; Cheng Q
Mol Neurobiol; 2016 Oct; 53(8):5772-81. PubMed ID: 26497032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
